Raydiant Oximetry, Inc. Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2015

Location

San Ramon CA US

Primary Industry

Medical Devices & Equipment

About

Based in California, US, and founded in 2015, Raydiant Oximetry, Inc., a.k.a. Raydiant Oximetry operates as a healthcare technology company focused on enhancing maternal-fetal medicine through its solutions. In May 2024, Raydiant Oximetry, Inc. raised USD 7.5 million in a Series A funding led by Cross-Border Impact Ventures, RH Capital, Global Health Impact Fund, VCapital, and the March of Dimes Innovation Fund. The series A funding values Raydiant Oximetry, Inc. at USD 25.37 million post-money. The company is developing Lumerah™, a noninvasive fetal pulse oximeter designed to accurately measure fetal oxygen levels during labor. Lumerah addresses the limitations of current electronic fetal monitoring, which has not significantly reduced neonatal injuries or stillbirths despite a high rate of cesarean deliveries in the U.S. The company plans to use its proceeds from May 2024 funding to fund two clinical trials, including the Daisy and Lumerah technologies.

Current Investors

AngelMD, Band of Angels, Mass Medical Angels

Request a demo to show more

Primary Industry

Medical Devices & Equipment

Sub Industries

Healthcare IT, Monitoring Equipment, Medical Software

Website

www.raydiantoximetry.com

Verticals

HealthTech

Company Stage

Series A

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.